*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : RQ3850000
CHEMICAL NAME : 2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-
CAS REGISTRY NUMBER : 1665-48-1
BEILSTEIN REFERENCE NO. : 0884592
LAST UPDATED : 199612
DATA ITEMS CITED : 4
MOLECULAR FORMULA : C12-H15-N-O3
MOLECULAR WEIGHT : 221.28
WISWESSER LINE NOTATION : T5MVOTJ D1OR C1 E1
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* AHR-438
* CL 39,148
* 5-((3,5-Dimethylphenoxy)methyl)-2-oxazolidinone
* Metaxalone
* Metazalone
* Metazolone
* Skelaxin
* Zorane
* 5-((3,5-Xylyloxy)methyl)-2-oxazolidinone
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 775 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,261,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 515 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 17,242,1967
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1690 mg/kg
TOXIC EFFECTS :
Behavioral - muscle weakness
Behavioral - rigidity (including catalepsy)
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 233,326,1978
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 490 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,261,1972
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
2-Oxazolidinone,5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-
| 139-91-3 |
2-Oxazolidinone,5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, monohydrochloride
| 3759-92-0 |
2-Oxazolidinone,5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, L-, monohydrochloride
| 3031-51-4 |
2-Oxazolidinone,5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, methiodide
| 3031-51-4 |
2-Oxazolidinone,5-(morpholinomethyl)-3-(((5-nitro-2-furoyl)methylene)amino)-
| 92297-09-1 |
2-Oxazolidinone,5-(morpholinomethyl)-3-(((5-nitro-2-furoyl)methylene)amino)-, hydrochloride
| 97158-93-5 |
Oxayohimban-16-carboxylic acid,16,17-didehydro-10,11-dimethoxy-19-methyl-, methylester, (3-beta,19-alpha,20-alpha)-
| 131-02-2 |
2-Oxazolidinone,5-(morpholinomethyl)-3-(((5-nitro-2-furoyl)methylene)amino)-, methiodide
| 97619-17-5 |
2-Oxazolidinone,5-(morpholinomethyl)-3-((3-(5-nitro-2-furyl)allylidene)amino)-
| 3318-79-4 |
2-Oxazolidinone,5-(morpholinomethyl)-3-((5-nitro-1-methyl-2-imidazolyl)methyleneamino)-, hydrochloride
| 30185-92-3 |
2-Oxazolidinone, 5-(morpholinomethyl)-3-phenyl-,monohydrochloride
| 27125-00-4 |
2-Oxazolidinone, 3-((5-nitrofurfurylidene)amino)-
| 67-45-8 |
2-Oxazolidinone,3-((5-nitro-2-furfurylidene)amino)-5-((4-octyl-1-piperazinyl)methyl)-, dihydrochloride
| 96059-01-7 |
2-Oxazolidinone,3-((5-nitro-2-furfurylidene)amino)-5-((4-propyl-1-piperazinyl)methyl)-
| 94374-28-4 |
2-Oxazolidinone,3-(((5-nitro-2-furoyl)methylene)amino)-
| 90323-37-8 |
2-Oxazolidinone,3-((3-(5-nitro-2-furyl)allylidene)amino)-
| 3318-78-3 |
2-Oxazolidinone,3-(p-nitrophenyl)-5-(2-propynyloxymethyl)-
| 23598-64-3 |
Oxayohimban-16-carboxylic acid,16,17-didehydro-1,19-dimethyl-, hydrazide,(19-alpha)-
| 72442-35-4 |
2-Oxazolidinone, 5-((2-phenoxyphenyl)methyl)-
| 62826-06-6 |
2-Oxazolidinone, 5-phenyl-
| 7693-77-8 |
2-Oxazolidinone, 5-(phenylmethyl)-
| 42746-49-6 |
2-Oxazolidinone, 3-phenyl-5-(piperidinomethyl)-,monohydrochloride
| 27125-08-2 |
2-Oxazolidinone, 3-phenyl-5-(2-propynyloxymethyl)-
| 23598-54-1 |
2-Oxazolidinone, 5-(1-piperidinylmethyl)-3-propyl-,monohydrobromide
| 52467-73-9 |
2-Oxazolidinone, 5-((2-(2-propenyloxy)phenyl)methyl)-
| 62826-13-5 |
2-Oxazolidinone, 3-propyl-5-(2-propynyloxymethyl)-
| 23598-89-2 |
2-Oxazolidinone, 5-phenyl-3-(1-pyrrolidinylcarbonyl)-
| 55243-73-7 |
2-Oxazolidinone, 5-(2-propynyloxymethyl)-3-(m-tolyl)-
| 23598-51-8 |
Oxayohimban-16-carboxylic acid,16,17-didehydro-1,19-dimethyl-, hydrazide,(19-alpha,20- alpha)-
| 72407-42-2 |
2-Oxazolidinone, 5-(2-propynyloxymethyl)-3-(o-tolyl)-
| 23598-52-9 |
2-Oxazolidinone, 5-(2-propynyloxymethyl)-3-(p-tolyl)-
| 23598-50-7 |
2-Oxazolidinone,5-(2-propynyloxymethyl)-3-(alpha,alpha,alpha-trifluoro-m-tolyl)-
| 23598-53-0 |
2-Oxazolidinone,5-(2-propynyloxymethyl)-3-(alpha,alpha,alpha-trifluoro-o-tolyl)-
| 23598-61-0 |
2-Oxazolidinone,5-(2-propynyloxymethyl)-3-(alpha,alpha,alpha-trifluoro-p-tolyl)-
| 23598-48-3 |
2-Oxazolidinone,5-((2-(trifluoromethyl)phenyl)methyl)-
| 62826-05-5 |
2-Oxazolidinone,5-((3-(trifluoromethyl)phenyl)methyl)-
| 62826-04-4 |
2-Oxazolidinone, 3-(3,4,5-trimethoxybenzoyl)-
| 50915-99-6 |
2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-
| 1665-48-1 |
2-Oxazolidone, 3-((2-furanylmethylene)amino)-
| 6270-33-3 |
Oxayohimban-16-carboxylic acid,16,17-didehydro-10-methoxy-19-methyl-, hydrazide,(19-alpha)-
| 72407-38-6 |
2-Oxazolidone,3-(furfurylideneamino)-4-(piperidinomethyl)-
| 126268-12-0 |
2-Oxazolidone, 3-(3-furyl-2-propenylideneamino)-
| 126268-04-0 |
2-Oxazolidone,3-((1-methylpyrrol-2-yl)methyleneamino)-
| 126268-08-4 |
2-Oxazolidone,3-((1-methylpyrrol-2-yl)methyleneamino)-4-(piperidinomethyl)-
| 126268-14-2 |
2-Oxazolidone, 3-((m-nitrophenyl)methyleneamino)-
| 35407-07-9 |
2-Oxazolidone, 3-((o-nitrophenyl)methyleneamino)-
| 19687-73-1 |
2-Oxazolidone, 3-((p-nitrophenyl)methyleneamino)-
| 90946-87-5 |
2-Oxazolidone, 3-(phenylmethyleneamino)-
| 4341-14-4 |
2-Oxazolidone, 3-(pyrrol-2-ylmethyleneamino)-
| 126268-10-8 |
2-Oxazolidone,3-(pyrrol-2-ylmethyleneamino)-4-(piperidinomethyl)-
| 126268-13-1 |
|
|